Outcomes of CD20 Bispecific Antibodies after CD19 CAR T-cell Therapy in mantle cell lymphoma: A Multicenter Analysis from the Collaborative U.S. Bispecific Consortium (CUBIC)Ajay Major, Andrew Jallouk, Robert Redd et al.|Transplantation and Cellular Therapy|2026Cited by 0